Medical

Standard medical procedures often require significant time and fail to account for individual patient characteristics, potentially affecting treatment success and quality of life.

A research project funded by Cancer Research UK is set to transform breast screening accessibility for patients with paralysis or other mobility issues.

Biodegradable electronics present a significant advancement in medical technology, enabling devices such as drug delivery systems, pacemakers, and neural implants to safely degrade into materials absorbed by the body once they are no longer needed.

In the rapidly evolving landscape of healthcare, the integration of digital solutions has become paramount in enhancing the quality of care provided in residential care homes. The KareInn app stands at the forefront of this digital revolution, offering a comprehensive platform designed to streamline care management and improve outcomes for residents.

MintNeuro has launched the ‘EXPLORE’ project, supported by a £100,000 grant from Innovate UK as part of the Biomedical Catalyst Feasibility Competition 2023.

Peterborough City Hospital have launched a groundbreaking trial, integrating artificial intelligence (AI) software into the digital pathology reporting of breast biopsies.

In the infinite and often intangible fathoms of the cosmos, one company is looking to the stars – or more specifically, Low Earth Orbit – to build a pharmaceutical factory in space that will create crystalline antibodies to help those on earth. 

A former principal mechanical engineer from a leading UK prosthetics firm has achieved notable advancements in creating more comfortable, functional, and affordable upper limb prosthetics through Heriot-Watt University's DeepTech LaunchPad programme.

With the 2024 Paris Games upon us, technology has become indispensable for maximising athlete performance. It has transformed how athletes train. Richard Godfrey, CEO and Co-Founder of Rocketmakers further explores.

Recent research indicates that 57% of the UK population is apprehensive about the swift adoption of AI in personalised medicine.